We are a purpose-driven AI company that combines scientific excellence, impact orientation and entrepreneurial drive. We leverage our unique technology and hands-on approach to help our clients unlock substantial value, fast.
Our Vision
Unlocking any target with superior small molecule drugs.
Our Misson
The strongest platform for rapid discovery of safe and effective small molecule drugs exploiting optimal modes of action.
OUR TECHNOLOGY
molab.ai provides a step change in drug discovery through impact-oriented applications of its cutting-edge technology.
End-to-end discovery platform
Platform integrating in-silico design and evaluation with wet lab validation. After simulations-based identification of the optimal binding site and mode of action, a combination of ultra-large virtual libraries screens with both AI/ML and physic-based methods, in silico ADMET prediction and generative molecular design as well as wet lab validation accelerate projects substantially.
ADMET prediction engine
Proven ADMET predictions and a reliable confidence indicator accelerating hit-to-lead and lead optimization projects by 25% – 40% through actionable recommendations and very robust performance in novel chemical space.
Compound optimization suite
GenAI-powered and curated suggestions for novel, alternative molecular structures optimized for potency, selectivity and desirable ADMET properties.